Symbolbild · KI-generiert
Alvotech
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Alvotech is an Icelandic biopharmaceutical company specialising in the development and manufacture of biosimilars. The company markets biosimilars to biological reference products such as adalimumab and other antibody therapies. Alvotech works with distribution partners across various global markets.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Alvotech | ALVO | NASDAQ | 1,29 Mrd. USD |
| Integra LifeSciences Holdings Corporation | IART | NASDAQ | 1,29 Mrd. USD |
| Avalyn Pharma Inc. | AVLN | NASDAQ | 1,28 Mrd. USD |
| Eton Pharmaceuticals, Inc. | ETON | NASDAQ | 1,27 Mrd. USD |
| Artivion, Inc. | AORT | NYSE | 1,30 Mrd. USD |
| MannKind Corporation | MNKD | NASDAQ | 1,25 Mrd. USD |
| Personalis, Inc. | PSNL | NASDAQ | 1,33 Mrd. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.